Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gain Therapeutics (GANX) Change in Receivables (2020 - 2021)

Historic Change in Receivables for Gain Therapeutics (GANX) over the last 2 years, with Q4 2021 value amounting to -$24429.0.

  • Gain Therapeutics' Change in Receivables fell 46532.08% to -$24429.0 in Q4 2021 from the same period last year, while for Dec 2021 it was -$8264.0, marking a year-over-year decrease of 431632.65%. This contributed to the annual value of -$8264.0 for FY2021, which is 431632.65% down from last year.
  • Gain Therapeutics' Change in Receivables amounted to -$24429.0 in Q4 2021, which was down 46532.08% from -$328453.0 recorded in Q3 2021.
  • In the past 5 years, Gain Therapeutics' Change in Receivables registered a high of $513738.0 during Q1 2021, and its lowest value of -$328453.0 during Q3 2021.